Literature DB >> 8586459

From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage.

M Noble1, N Gutowski, K Bevan, U Engel, M Linskey, J Urenjak, K Bhakoo, S Williams.   

Abstract

With only a few exceptions, the precursor cells representing the normal counterparts of human tumours are unknown. The comparative lack of information about the lineages involved in tissue development, and difficulties in growing many human tumors in a manner suitable for cellular biological analysis, together often make it difficult to study the differences between normal and tumor cells and to develop many of the model systems that would be useful in the study of human cancer. By applying techniques previously utilized to study glial progenitor cells, we have isolated a human glioblastoma multiforme (GBM)-derived population that expresses many properties otherwise uniquely expressed by oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Hu-O-2A/Gb1 (for Human O-2A lineage Glioblastoma number 1) cells responded to similar mitogens and differentiation modulators as rodent O-2A progenitors, and generated cells with features of precursor cells, oligodendrocytes and astrocytes. Moreover, 1H-NMR analysis of amino acid composition demonstrated a striking conversation of types and quantities of free amino acids between the human tumour cells and the rodent primary cells. Hu-O-2A/Gb1 cells represent the first human glioma-derived population for which unambiguous lineage assignment has been possible, and our results indicate that the human O-2A lineage can contribute to one of the most malignant of glial tumours. In addition, the highly diagnostic 1H-NMR spectrum expressed by Hu-O-2A/Gb1 cells raises the possibility of eventual non-invasive identification of tumors of this lineage.

Entities:  

Mesh:

Year:  1995        PMID: 8586459     DOI: 10.1002/glia.440150304

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

1.  Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme.

Authors:  X Mao; R Barfoot; R A Hamoudi; M Noble
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

2.  The role of molecular biology in neurosurgery. Meeting of the Research Committee of the EANS in Hamburg, March 3-5, 1995.

Authors:  M Westphal; M Gerosa; R Fahlbusch
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  A tripotential glial precursor cell is present in the developing spinal cord.

Authors:  M S Rao; M Noble; M Mayer-Pröschel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.

Authors:  Charles Nicaise; Dinko Mitrecic; Aditi Falnikar; Angelo C Lepore
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.

Authors:  Q R Lu; J K Park; E Noll; J A Chan; J Alberta; D Yuk; M G Alzamora; D N Louis; C D Stiles; D H Rowitch; P M Black
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 6.  Growth factors, glia and gliomas.

Authors:  M Noble; M Mayer-Pröschel
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

7.  Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.

Authors:  Y Shoshan; A Nishiyama; A Chang; S Mörk; G H Barnett; J K Cowell; B D Trapp; S M Staugaitis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 8.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

Review 9.  Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.

Authors:  Per Ø Sakariassen; Heike Immervoll; Martha Chekenya
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Expression profiling of human glial precursors.

Authors:  James T Campanelli; Robert W Sandrock; Will Wheatley; Haipeng Xue; Jianhua Zheng; Feng Liang; Jonathan D Chesnut; Ming Zhan; Mahendra S Rao; Ying Liu
Journal:  BMC Dev Biol       Date:  2008-10-23       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.